X-54924677-A-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001271183.2(TRO):c.-59A>T variant causes a 5 prime UTR premature start codon gain change. The variant allele was found at a frequency of 0.00000744 in 1,210,108 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0000089 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.0000073 ( 0 hom. 4 hem. )
Consequence
TRO
NM_001271183.2 5_prime_UTR_premature_start_codon_gain
NM_001271183.2 5_prime_UTR_premature_start_codon_gain
Scores
1
5
11
Clinical Significance
Conservation
PhyloP100: 4.40
Genes affected
TRO (HGNC:12326): (trophinin) This gene encodes a membrane protein that mediates cell adhesion between trophoblastic cells and the epithelial cells of the endometrium. The encoded protein participates in cell signalling during embryo implantation, and may also be involved in cancer formation. This gene is located near several other closely related genes on chromosome X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.15847406).
BS2
High Hemizygotes in GnomAdExome4 at 4 gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000892 AC: 1AN: 112105Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34279
GnomAD3 genomes
AF:
AC:
1
AN:
112105
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34279
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000441 AC: 8AN: 181568Hom.: 0 AF XY: 0.0000593 AC XY: 4AN XY: 67416
GnomAD3 exomes
AF:
AC:
8
AN:
181568
Hom.:
AF XY:
AC XY:
4
AN XY:
67416
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000729 AC: 8AN: 1097947Hom.: 0 Cov.: 30 AF XY: 0.0000110 AC XY: 4AN XY: 363307
GnomAD4 exome
AF:
AC:
8
AN:
1097947
Hom.:
Cov.:
30
AF XY:
AC XY:
4
AN XY:
363307
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000892 AC: 1AN: 112161Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34345
GnomAD4 genome
AF:
AC:
1
AN:
112161
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34345
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
3
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 22, 2023 | The c.1349A>T (p.K450M) alteration is located in exon 5 (coding exon 4) of the TRO gene. This alteration results from a A to T substitution at nucleotide position 1349, causing the lysine (K) at amino acid position 450 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.;.;.;.;.;.
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;.;T;T;T;T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;N;.;N;.;.;.
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;.;D;D;D;D
REVEL
Benign
Sift
Benign
T;T;.;T;T;T;T
Sift4G
Uncertain
D;D;T;D;T;D;D
Polyphen
D;.;.;.;.;.;.
Vest4
MutPred
Loss of MoRF binding (P = 0.0465);Loss of MoRF binding (P = 0.0465);.;Loss of MoRF binding (P = 0.0465);.;.;.;
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at